Acadia Pharmaceuticals shares popped after the company announced that the FDA completed a postmarketing review and issued a clear statement reaffirming the positive benefit-risk profile of Nuplazid for patients with Parkinson’s disease psychosis.
GTx shares were absolutely crushed on Friday after the company announced results from its mid-stage trial in post-menopausal women with stress urinary incontinence.
United Natural Foods shares tumbled after it reported its most recent quarterly results after the markets closed on Thursday.
Micron released better-than-expected fiscal fourth-quarter financial results after the markets closed on Thursday.
Thursday was a very positive day for the broad U.S. markets with the S&P 500 and the Dow each hitting their all-time highs. Crude oil retreated slightly in the session. The S&P 500 sectors…
Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.
Eventbrite entered the market with a bang on Thursday, at a more than a 56% premium to the set share price.
Micron is set to report its fiscal fourth-quarter financial results late on Thursday, and analysts are looking for strong growth on the top and bottom lines.
Under Armour shares made a solid gain on Thursday after the company announced a restructuring plan and a new full year outlook. As part of this restructuring the firm is also cutting about 400…
Adverum Biotechnologies shares made a handy gain on Thursday after the company announced a key update from the FDA.
Nike faced some tough criticism and reactionary setbacks to its reputation when it announced former quarterback Colin Kaepernick as the face of its new “Just Do It” campaign. However, a new report found that…
Red Hat shares retreated after it reported mixed fiscal second-quarter financial results after the markets closed on Wednesday.
Wednesday was a positive day for the broad U.S. markets with the S&P 500 and the Dow within points of their all-time highs. Crude oil pushed back above $70 in the session as well.…
AbbVie shares took a dip on Wednesday after it was announced that the pharma giant would be facing a lawsuit from the California Department of Insurance in regards to allegedy kickbacks given to health…
Clovis shares might not be showing it now, but the company is facing some heat from the SEC over charges of misleading investors about the company’s developmental lung cancer drug.
Red Hat is scheduled to release its fiscal second-quarter financial results after the markets close on Wednesday, and analysts are looking for solid year-over-year growth.
Juniper Networks stock has seen a relatively flat year so far, and for the most part this is reflected in the analysts' calls. However, one analyst broke away from the consensus and issued an…
SeaWorld has long been at the center of controversy in regards to whether or not the company treats its animals humanely. Many would argue that this company’s reputation wasn’t the best in this case,…
SunPower had been having a tough year, but Tuesday brought on large gains after SunPower said that several of its products were going to be excluded from the U.S. tariffs.
While Oracle's fiscal first-quarter report was not that great, it wasn’t half bad either. Analysts seemed to take a cue from this and their responses to the report were not uniform, with some taking…
